Supreme Court Widens Scrutiny on Misleading FMCG Advertisements: Implications for Governance and Consumer Rights

The Supreme Court of India, while hearing the contempt petition against Patanjali Ayurved regarding misleading advertisements, has significantly expanded the scope of the case to include all Fast-Moving Consumer Goods (FMCG) companies. This judicial intervention marks a pivotal shift in how consumer protection and public health are viewed through the lens of the Indian Constitution.

The Bench, comprising Justices Hima Kohli and Ahsanuddin Amanullah, emphasized that misleading advertisements infringe upon the fundamental 'Right to Health' under Article 21. The court observed that consumers are often lured by unsubstantiated claims regarding the efficacy of products, particularly those marketed as 'natural' or 'herbal.' By widening the scrutiny, the court aims to ensure that every FMCG entity is held accountable for the scientific validity of its health-related claims.

A critical aspect of this development is the court's focus on regulatory lethargy. The Supreme Court questioned the Ministry of AYUSH and the Food Safety and Standards Authority of India (FSSAI) for their perceived inaction against deceptive marketing practices. This highlights a significant governance challenge: the gap between existing statutory frameworks—such as the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954, and the Consumer Protection Act, 2019—and their ground-level enforcement.

Furthermore, the court’s directive for FMCG companies to file self-declarations before airing advertisements introduces a new layer of corporate accountability. This move is expected to curb the 'celebrity endorsement' culture where influencers promote products without verifying their health impacts. For the governance of the food and health sectors, this case serves as a catalyst for strengthening the Central Consumer Protection Authority (CCPA) and refining the standards for 'misleading ads' in the digital age.